<b>Conclusions</b>: Our findings support targeting the Nrf2/HO-1 signaling pathway as a potential therapy for reversing hyperlipidemia and preventing mediators of inflammation and oxidative stress damage in the liver tissue. Here, HMOX1 is linked to hyperlipidemia.